← Leaderboards
Bruce Lee Rogers
Casterbridge Pharmaceuticals, Inc.
$224,448
Attributed
$448,895
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $225K · FY2017–18$250K$187.5K$125K$62.5K$0
'17
'18
Funding mix
By agency
NIH$448,895 · 2
By mechanism
R41$448,895 · 2
Top collaborators
- Lynda A. Morrison2 shared
Others in their field
Other Emerging Leaders on “Genetic Recombination”
- Gary Fanger · Rise Therapeutics, Llc$14,558,909
- Benjamin E Deverman · Broad Institute, Inc.$6,462,832
- Michael-Christopher Keogh · Epicypher, Inc.$6,348,104
- Alan S. Wayne · University Of Southern California$6,263,488
- Gene Tan · J. Craig Venter Institute, Inc.$5,686,063
- Yating Wang · Broad Institute, Inc.$4,966,476
Research focus
Genetic RecombinationHuman Herpesvirus 2Dna BiosynthesisEnzymesHerpesvirus 1Human DiseaseCommercializationDisease OutbreaksDrug DevelopmentEnzyme Inhibitor DrugsHerpesviridaeHerpesviridae InfectionsBirthBlindnessAmericanCombined Modality TherapyAcyclovirCorneaAnalogDrug CandidateBaseEncephalitisGenital SystemImmunocompromised Host